Get an alert when ALEXION PHARMA UK LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-10-31 (in 5mo)

Last made up 2025-10-17

Watchouts

None on the register

Cash

£3

-100% vs 2023

Net assets

£6M

-64.9% vs 2023

Employees

75

-7.4% vs 2023

Profit before tax

£6M

-1.4% vs 2023

Name history

Renamed 1 time since incorporation

  1. ALEXION PHARMA UK LIMITED 2006-11-03 → present
  2. PIMCO 2564 LIMITED 2006-10-17 → 2006-11-03

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £115,085,381£122,845,851
Operating profit £5,576,279£5,886,077
Profit before tax £6,458,282£6,369,682
Net profit £4,814,854£4,656,096
Cash £15,125£3
Total assets less current liabilities £15,943,999£5,600,095
Net assets £15,943,999£5,600,095
Equity £15,943,999£5,600,095
Average employees 8175
Wages £10,913,515£10,963,300

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 4.8%4.8%
Net margin 4.2%3.8%
Return on capital employed 35.0%105.1%
Current ratio 1.37x1.20x
Interest cover 8200.41x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
PricewaterhouseCoopers
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Based on their assessment of the Company's financial position, they continue to adopt the going concern basis in preparing the Financial Statements.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 18 resigned

Name Role Appointed Born Nationality
OLLE, Francesc Secretary 2025-08-31
ELLOIAN, Michael Ira Kenneth Director 2018-08-03 May 1972 American
OLLE, Francesc Director 2024-04-24 Jun 1987 Spanish
RICHARDS, Deborah Director 2024-04-24 Sep 1967 British
Show 18 resigned officers
Name Role Appointed Resigned
BHALLA, Mayank, Dr Secretary 2024-04-24 2025-09-01
DUFAUX, Philippe Secretary 2017-11-02 2024-02-02
OLLE, Francesc Secretary 2024-02-02 2024-04-18
PINSENT MASONS SECRETARIAL LIMITED Corporate Secretary 2006-10-17 2007-07-24
YORK PLACE COMPANY SECRETARIES LIMITED Corporate Secretary 2007-06-01 2017-11-02
BARRETT, Mark Shane Director 2007-06-01 2014-02-07
COISSAC, Patrice Director 2006-11-16 2009-06-15
DEVEQUE, Pierre Director 2007-09-01 2010-08-03
DUBIN, Thomas I H Director 2009-06-15 2010-08-03
FRAZER, Elaine Director 2016-12-06 2018-06-27
FRYER, Jeffrey Michael Director 2009-06-15 2016-12-06
GRECO, Michael Vincent Director 2010-08-03 2016-12-06
GREER, Vivien Ruth Director 2018-08-03 2022-07-15
KEISER, David Wharton Director 2007-09-01 2009-06-15
RICHARDSON, Sean Barnaby Robert Knox Director 2018-04-17 2024-04-18
TRAFFORD-JONES, Sara Director 2015-11-09 2018-04-17
WOODS, Robert Keith Director 2014-02-07 2015-12-15
PINSENT MASONS DIRECTOR LIMITED Corporate Director 2006-10-17 2006-11-16

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Alexion Pharmaceuticals, Inc. Corporate entity Shares 50–75%, Voting 50–75% 2016-04-06 Active

Filing timeline

Last 20 of 107 total filings

Date Type Category Description
2025-11-05 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-10-07 AA accounts Accounts with accounts type full
2025-09-10 CH01 officers Change person director company with change date PDF
2025-09-05 CH01 officers Change person director company with change date PDF
2025-09-05 AP03 officers Appoint person secretary company with name date PDF
2025-09-05 TM02 officers Termination secretary company with name termination date PDF
2024-10-29 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-10-11 AA accounts Accounts with accounts type full
2024-04-24 AP03 officers Appoint person secretary company with name date PDF
2024-04-24 AP01 officers Appoint person director company with name date PDF
2024-04-24 AP01 officers Appoint person director company with name date PDF
2024-04-23 TM02 officers Termination secretary company with name termination date PDF
2024-04-23 TM01 officers Termination director company with name termination date PDF
2024-02-19 AD01 address Change registered office address company with date old address new address PDF
2024-02-02 AP03 officers Appoint person secretary company with name date PDF
2024-02-02 TM02 officers Termination secretary company with name termination date PDF
2023-10-30 AA accounts Accounts with accounts type full
2023-10-18 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-11-03 AA accounts Accounts with accounts type full
2022-10-17 CS01 confirmation-statement Confirmation statement with no updates PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
6

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page